Combination therapy can prevent resistance to treatment in hormone responsive metastatic breast cancer patients
Breast cancer is a heterogeneous disease, but 70% of cases are characterized by the presence of hormone receptors for estrogen, progesterone, or both. The first line of treatment for these patients, when presenting with metastatic ...
Jul 13, 2023
0
1